539
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

An echocardiographic predictor of contrast-induced nephropathy following percutaneous coronary intervention in acute coronary syndrome: aortic valve sclerosis

, , , , , , & show all
Pages 227-231 | Received 24 Jul 2019, Accepted 31 Jan 2020, Published online: 19 Feb 2020

References

  • Neumann FJ, Sousa-Uva M, Ahlsson A. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019 Jan 7;40(2):87–165.
  • Senoo T, Motohiro M, Kamihata H, et al. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2010;105(5):624–628.
  • Perrin T, Descombes E, Cook S. Contrast-induced nephropathy in invasive cardiology. Swiss Med Wkly. 2012;142:w13608.
  • Caspi O, Habib M, Cohen Y, et al. Acute kidney injury after primary angioplasty: is contrast-induced nephropathy the culprit? J Am Heart Assoc. 2017 Jun 24;6(6):e005715.
  • Barbieri L, Verdoia M, Schaffer A, et al. Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention. Diabetes Res Clin Pract. 2014;106(3):458–464.
  • Han B, Li Y, Dong Z, et al. Diastolic dysfunction predicts the risk of contrast-induced nephropathy and outcome post-emergency percutaneous coronary intervention in AMI patients with preserved ejection fraction. Heart Vessels. 2018;33(10):1149–1158.
  • Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004 6;44(7):1393–1399.
  • Gungoren F, Besli F, Tanriverdi Z, et al. Inferior vena cava assessment can predict contrast-induced nephropathy in patients undergoing cardiac catheterization: a single-center prospective study. Echocardiography. 2018;35(12):1915–1921.
  • Erdogan T, Cetin M, Kocaman SA, et al. Aortic valve sclerosis is a high predictive marker of systemic endothelial dysfunction in hypertensive patients. Herz. 2013;38(8):915–921.
  • Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267–315.
  • Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–470.
  • Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–270.
  • Otto CM, Lind BK, Kitzman DW, et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341(3):142–147.
  • Chandra HR, Goldstein JA, Choudhary N, et al. Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. J Am Coll Cardiol. 2004;43(2):169–175.
  • Cosmi JE, Kort S, Tunick PA, et al. The risk of the development of aortic stenosis in patients with “benign” aortic valve thickening. Arch Intern Med. 2002;162(20):2345–2347.
  • Shah SJ, Ristow B, Ali S, et al. Acute myocardial infarction in patients with versus without aortic valve sclerosis and effect of statin therapy (from the Heart and Soul Study). Am J Cardiol. 2007;99(8):1128–1133.
  • Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3):630–634.
  • Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994;90(2):844–853.
  • Yang ZK, Ying C, Zhao HY, et al. Mineral metabolism disturbances are associated with the presence and severity of calcific aortic valve disease. J Zhejiang Univ Sci B. 2015;16(5):362–369.
  • Kwasa EA, Vinayak S, Armstrong R. The role of inflammation in contrast-induced nephropathy. BJR. 2014 Sep;87(1041):20130738.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.